World Health Organization: Global Hepatitis Report. 2017. https://www.who.int/global hepatitis report. Accessed 24 Oct 2020.
Google Scholar
Woodyatt CR. World AIDS day 2018. Ann Epidemiol. 2018;28(12):829. https://doi.org/10.1016/j.annepidem.2018.10.009.
Article
PubMed
Google Scholar
Ministry of Health, Community Development, Gender, Health and Children. National strategic plan for control of viral hepatitis. 2018. https://www.moh.go.tz/national strategic plan for the control of viral hepatitis. Accessed 25 Sept 2020.
Google Scholar
National Bureau of Statistics. Tanzania HIV Impact Survey. 2019. https://www.nbs.go.tz/HIV impact survey. Accessed 19 Oct 2020.
Google Scholar
Kawambwa RH, Majigo MV, Mohamed AA, Matee MI. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania. BMC Public Health. 2020;20:1.
Article
Google Scholar
Dahoma MJ, Salim AA, Abdool R, Othman AA, Makame H, Ali AS, et al. HIV and substance abuse: the dual epidemics challenging Zanzibar. African J Drug Alcohol Stud. 2006;5(2):128.
Google Scholar
Leyna GH, Makyao N, Mwijage A, Ramadhan A, Likindikoki S, Mizinduko M, et al. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination. Harm Reduct J. 2019;16(1):1.
Article
Google Scholar
Khatib A, Matiko E, Khalid F, Welty S, Ali A, Othman A, et al. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar. BMC Public Health. 2017;17(1):1–6.
Article
Google Scholar
National AIDS Control Programme. Consensus estimates on key population size and HV prevalence in Tanzania. 2014. https://www.healthpolicyproject.com/consensus report. Accessed 01 Oct 2020.
Google Scholar
Ndayongeje J, Msami A, Laurent YI, Mwankemwa S, Makumbuli M, Ngonyani AM, et al. Illicit drug users in the Tanzanian hinterland: population size estimation through key informant-driven hot spot mapping. AIDS Behav. 2018;22(1):4–9. https://doi.org/10.1007/s10461-018-2057-x.
Article
PubMed
PubMed Central
Google Scholar
Ministry of Health, Community Development, Gender, Elderly and Children. National standard operating procedures for management of Opioid use disorders. 2019. https://www.moh.go.tz/national standard operating procedures for management of Opiod use disorders. Accessed 26 Aug 2020.
Google Scholar
Ministry of Health, Community Development, Gender, Elderly and Children. National comprehensive guidelines on HIV testing services. 2019. http://www.nacp.go.tz/national comprehensive guidelines on HIV testing services. Accessed 07 Aug 2020.
Google Scholar
Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, et al. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. Int J Drug Policy. 2017;45:64–9. https://doi.org/10.1016/j.drugpo.2017.05.043.
Article
PubMed
PubMed Central
Google Scholar
Rashti R, Sharafi H, Alavian SM, Moradi Y, Bolbanabad AM, Moradi G. Systematic review and meta-analysis of global prevalence of HBsAg and HIV and HCV antibodies among people who inject drugs and female sex workers. Pathogens. 2020;9(6):432. https://doi.org/10.3390/pathogens9060432.
Article
CAS
PubMed Central
Google Scholar
Baltazar CS, Horth R, Boothe M, Sathane I, Young P, Langa DC, et al. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique. BMC Infect Dis. 2019;19:1022.
Article
Google Scholar
Baltazar CS, Boothe M, Kellogg T, Ricardo P, Sathane I, Fazito E, et al. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique. BMC Public Health. 2020;20(1):851. https://doi.org/10.1186/s12889-020-09012-w.
Article
CAS
Google Scholar
Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5(12):e1192–207. https://doi.org/10.1016/S2214-109X(17)30375-3.
Article
Google Scholar
Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Mansoori KB. Methadone maintenance therapy outcomes in Iran. Subst Use Misuse. 2012;47(7):767–73. https://doi.org/10.3109/10826084.2010.517726.
Article
PubMed
Google Scholar
Tran BX, Nguyen LT. Impact of Methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS. Int J Drug Policy. 2013;24(6):e105–10.
Article
Google Scholar
Zhang L, Zou X, Xu Y, Medland N, Deng L, Liu Y, et al. The decade-long Chinese methadone maintenance therapy yields large population and economic benefits for drug users in reducing harm, HIV and HCV disease burden. Front Public Heal. 2019;7:327.
Article
Google Scholar
Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, et al. Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania. Int J Drug Policy. 2016;30:74–81. https://doi.org/10.1016/j.drugpo.2016.03.005.
Article
PubMed
PubMed Central
Google Scholar
Van-Den C, Smit C, Van-Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users. Addiction. 2007;102(9):1454–62. https://doi.org/10.1111/j.1360-0443.2007.01912.x.
Article
Google Scholar
Mmbaga EJ, Moen K, Makyao N, Leshabari M. Prevalence and predictors of human immunodeficiency virus and selected sexually transmitted infections among people who inject drugs in Dar es Salaam, Tanzania. Sex Transm Dis. 2017;44(2):79–84. https://doi.org/10.1097/OLQ.0000000000000555.
Article
PubMed
Google Scholar
Leung J, Peacock A, Colledge S, Grebely J, Cunningham EB, Hickman M, et al. A global meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject drugs - do gender-based differences vary by country-level indicators? J Infect Dis. 2019;220(1):78–90. https://doi.org/10.1093/infdis/jiz058.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Int J Drug Policy. 2017;47:144–52. https://doi.org/10.1016/j.drugpo.2017.05.041.
Article
PubMed
PubMed Central
Google Scholar
Cohen-Moreno R, Schiff M, Levitt S, Bar-Hamburger R, Strauss S, Neumark Y. Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. Subst Use Misuse. 2010;45(1–2):58–76. https://doi.org/10.3109/10826080902864894.
Article
PubMed
Google Scholar
Ministry of Health, Community Development, Gender, Elderly and Children. National guidelines for comprehensive management of Opioid use disorder. 2019. https://www.moh.go.tz/guidelines for comprehensive management of opioid use disorder. Accessed 02 Aug 2020.
Google Scholar
Aaron D, Nagu TJ, Rwegasha J, Komba E. Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much? Who and why? BMC Infect Dis. 2017;17(1):786. https://doi.org/10.1186/s12879-017-2893-8.
Article
PubMed
PubMed Central
Google Scholar
Shao ER, Mboya IB, Gunda DW, Ruhangisa FG, Temu EM, Nkwama ML. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infect Dis. 2018;18(1):474. https://doi.org/10.1186/s12879-018-3376-2.
Article
PubMed
PubMed Central
Google Scholar
Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich B. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania. BMC Infect Dis. 2015;15(1):386. https://doi.org/10.1186/s12879-015-1129-z.
Article
CAS
PubMed
PubMed Central
Google Scholar